Giovannoni G, et al. Treatment outcomes of daclizumab in patients at high risk of transitioning to secondary progressive multiple sclerosis in DECIDE. EAN 2107, O2113.
Sublinguaal apomorfine effectieve behandeling voor off-periodes bij Parkinson
feb 2020 | Bewegingsstoornissen